Right-wing pundit Megyn Kelly lashed out at Taylor Swift after the pop superstar threw her support behind presidential candidate Kamala Harris. The 34-year-old global phenomenal officially endorsed ...
Former Australian Prime Minister Kevin Rudd once called Rupert Murdoch a cancer on our society. Now, that cancer is trying to ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
For the first time in the organization's history, all of the honourees are women. Each honouree is dedicated to creating ...
Vice President Kamala Harris’ presidential campaign touts its refusal to accept contributions from corporate PACs, all while ...
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.
In the TRUST-II trial, 85 percent of ROS1 TKI-naïve NSCLC patients and in 62 percent of TKI-pretreated patients responded to the next-generation ROS1 inhibitor.
The limitations of currently available therapies for immune thrombocytopenia (ITP) mean that long-term responses are ...
Zacks.com on MSN11h
Pfizer (PFE) Upgraded to Buy: What Does It Mean for the Stock?Pfizer (PFE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...
On the heels of Terns’ positive Phase I results that analysts compared with Lilly’s and Pfizer’s weight loss pills in ...
Former President Donald Trump shrugged off Taylor Swift’s endorsement of Vice President Kamala Harris in the 2024 election, predicting Wednesday that the megastar may “pay a price for ...
Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback